ephrin-A4 Double Nickase Plasmid (h): sc-404603-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- ephrin-A4 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- ephrin-A4 Double Nickase Plasmid (h) and ephrin-A4 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting EFNA4. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ephrin-A4 Double Nickase Plasmid (h) | sc-404603-NIC | 20 µg | $410.00 | |||
ephrin-A4 Double Nickase Plasmid (h2) | sc-404603-NIC-2 | 20 µg | $410.00 |
EFNA4 encodes ephrin-A4, a glycosylphosphatidylinositol-anchored ligand for Eph receptor tyrosine kinases that mediates contact-dependent cell–cell signaling. Eph/ephrin interactions regulate axon guidance, tissue boundary formation, cell adhesion, and cytoskeletal remodeling through pathways that converge on Rho-family GTPases and downstream MAPK/PI3K signaling nodes. In human cells, ephrin-A4 activity influences migratory and invasive phenotypes, angiogenic patterning, and epithelial–mesenchymal-like programs in a context-dependent manner. Altered EFNA4 expression or Eph/ephrin signaling imbalance has been reported across multiple cancer types and in neurodevelopmental processes, making it a useful entry point for studying signaling-driven cellular organization.
ephrin-A4 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the EFNA4 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within EFNA4. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt EFNA4 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of EFNA4-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.